1. Home
  2. LPCN vs MSGM Comparison

LPCN vs MSGM Comparison

Compare LPCN & MSGM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • MSGM
  • Stock Information
  • Founded
  • LPCN 1997
  • MSGM 2018
  • Country
  • LPCN United States
  • MSGM United States
  • Employees
  • LPCN N/A
  • MSGM N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • MSGM Computer Software: Prepackaged Software
  • Sector
  • LPCN Health Care
  • MSGM Technology
  • Exchange
  • LPCN Nasdaq
  • MSGM Nasdaq
  • Market Cap
  • LPCN 16.1M
  • MSGM 13.8M
  • IPO Year
  • LPCN N/A
  • MSGM 2021
  • Fundamental
  • Price
  • LPCN $3.29
  • MSGM $2.85
  • Analyst Decision
  • LPCN Strong Buy
  • MSGM Hold
  • Analyst Count
  • LPCN 2
  • MSGM 1
  • Target Price
  • LPCN $9.00
  • MSGM $5.00
  • AVG Volume (30 Days)
  • LPCN 59.4K
  • MSGM 49.7K
  • Earning Date
  • LPCN 08-07-2025
  • MSGM 08-08-2025
  • Dividend Yield
  • LPCN N/A
  • MSGM N/A
  • EPS Growth
  • LPCN N/A
  • MSGM N/A
  • EPS
  • LPCN N/A
  • MSGM N/A
  • Revenue
  • LPCN $3,674,834.00
  • MSGM $7,416,879.00
  • Revenue This Year
  • LPCN N/A
  • MSGM $69.07
  • Revenue Next Year
  • LPCN N/A
  • MSGM $30.56
  • P/E Ratio
  • LPCN N/A
  • MSGM N/A
  • Revenue Growth
  • LPCN N/A
  • MSGM N/A
  • 52 Week Low
  • LPCN $2.68
  • MSGM $0.73
  • 52 Week High
  • LPCN $8.71
  • MSGM $3.50
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 51.52
  • MSGM 52.94
  • Support Level
  • LPCN $3.13
  • MSGM $2.69
  • Resistance Level
  • LPCN $3.53
  • MSGM $2.90
  • Average True Range (ATR)
  • LPCN 0.24
  • MSGM 0.14
  • MACD
  • LPCN 0.01
  • MSGM -0.04
  • Stochastic Oscillator
  • LPCN 48.33
  • MSGM 46.11

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About MSGM Motorsport Games Inc.

Motorsport Games Inc is a motorsport network company that combines engaging video games with esports competitions and content for racing fans and gamers around the globe. The company has its reportable segments into the development and publishing of interactive racing video games, entertainment content and services, and the organization and facilitation of esports tournaments, competitions, and events for licensed racing games as well as on behalf of third-party video game racing series and other video game publishers. The majority of the revenue is earned from Gaming.

Share on Social Networks: